HLA-DRB1 and myeloid sarcoma: Using a large dataset of MS cases early in their diagnosis with age/sex/location-matched controls, we confirmed previous findings that DNA methylation acts as mediator of the HLA-DRB1*1501 allele [16] and provided evidence that this occurs early in disease pathology rather than as a result of treatment or long-standing disease.